Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expression
- 31 December 1995
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 173 (6), 1829-1834
- https://doi.org/10.1016/0002-9378(95)90436-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Expression of c-erbb-2 protein and epidermal growth factor receptor in endometrial carcinomas correlation with clinicopathologic and sex steroid receptor statusCancer, 1993
- HER-2/neu expression: A major prognostic factor in endometrial cancerGynecologic Oncology, 1992
- Immunohistochemical study of c‐erbB‐2 oncoprotein overexpression in human major salivary gland carcinoma: An indicator of aggressivenessThe Laryngoscope, 1992
- Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpusCancer, 1992
- Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage diseaseAmerican Journal of Obstetrics and Gynecology, 1991
- Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of PatientsJapanese Journal of Cancer Research, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The significance of residual disease after radiotherapy in endometrial carcinoma: Clinicopathologic correlationAmerican Journal of Obstetrics and Gynecology, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958